Treatment of high potassium with Kayexalate powder in hemodialysis
https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1445
- Available Online
- View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Polystyrene sulfonic acid
- Hyperkalemia
- Subjects (LCSH)
- Drugs
- Low-potassium diet
- Specialty
- Nephrology
- Medications
- Abstract
- Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
- Notes
- Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1445
Managing your fluid intake in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35545
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0538
- Available Online
- View Pamphlet
This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases - diet therapy
- Subjects (LCSH)
- Kidneys--Diseases--Nutritional aspects
- Abstract
- This pamphlet explains how to maintain an ideal balance of fluid in your body when managing chronic kidney disease.
- Notes
- Previous title: Managing your fluid intake in chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 0538
Erythropoieis-stimulating agents (ESAs) for people with chronic kidney disease (CKD) and active cancer or a history of cancer or stroke
https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2217
- Available Online
- View Pamphlet
If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Anemia - drug therapy
- Hematinics - therapeutic use
- Neoplasms
- Stroke
- Subjects (LCSH)
- Chronic renal failure--Complications
- Hematopoietic growth factors
- Renal anemia--Chemotherapy
- Cancer
- Cerebrovascular disease
- Abstract
- If you have chronic kidney disease (CKD), your health care provider may order erythropoieis-stimulating agent (ESA) medications for you. This pamphlet explains the risks and benefits of ESAs if you have CKD and active cancer, or a history of cancer or stroke.
- Notes
- Previous title: Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2217
Pruritis (itchy skin) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams38252
Nova Scotia Health Authority. Renal Pharmacy Team, Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2385
- Available Online
- View Pamphlet
Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Pharmacy Team
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases
- Pruritis
- Subjects (LCSH)
- Kidney disease
- Skin
- Itching
- Abstract
- Pruritis is an itchy feeling on or under your skin. This pamphlet explains what causes pruritis in people with CKD, what the symptoms are, how you can prevent it, and how your kidney team will treat it.
- Responsibility
- Prepared by: Renal Pharmacy Team, Renal Program
- Pamphlet Number
- 2385
Cyclosporine for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38298
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2418
- Available Online
- View Pamphlet
Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Cyclosporine
- Glomerulonephritis
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Cyclosporine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2418
Prednisone for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38299
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2419
- Available Online
- View Pamphlet
Prednisone is a type of medication known as a corticosteroid. It works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Prednisone
- Glomerulonephritis
- Adrenal Cortex Hormones - therapeutic use
- Subjects (LCSH)
- Adrenocortical hormones
- Kidneys--Diseases--Treatment
- Abstract
- Prednisone is a type of medication known as a corticosteroid. It works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2419
Mycophenolate for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38300
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2420
- Available Online
- View Pamphlet
Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Mycophenolic Acid
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Mycophenolate mofetil or mycophenolic acid is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2420
Azathioprine for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38301
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2421
- Available Online
- View Pamphlet
Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Azathioprine
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Azathioprine is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2421
Cyclophosphamide for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38303
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2422
- Available Online
- View Pamphlet
Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Cyclophosphamide
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Cyclophosphamide is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2422
Rituximab for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38304
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2423
- Available Online
- View Pamphlet
Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Rituximab
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Rituximab is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and if this medication is safe during pregnancy and breastfeeding.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2423
Tacrolimus for glomerulonephritis
https://libcat.nshealth.ca/en/permalink/chpams38305
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2424
- Available Online
- View Pamphlet
Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Tacrolimus
- Glomerulonephritis
- Immunosuppressive Agents
- Subjects (LCSH)
- Immunosuppressive agents
- Kidneys--Diseases--Treatment
- Abstract
- Tacrolimus is a medication that works by lowering your body’s harmful response to immune system diseases like glomerulonephritis. This pamphlet explains how to take this medication, possible side effects, and how to store this medication.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2424
Prevnar® 20 (Pneumococcal Conjugate Vaccine) and kidney disease
https://libcat.nshealth.ca/en/permalink/chpams38309
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 2427
- Available Online
- View Pamphlet
Prevnar® 20 is a vaccine that protects against infections caused by Streptococcus pneumoniae bacteria. This pamphlet explains why you may need to get vaccinated, possible side effects of the vaccine, and who should not get the vaccine.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Kidney Diseases
- Vaccines
- Subjects (LCSH)
- Kidneys--Diseases
- Vaccines
- Abstract
- Prevnar® 20 is a vaccine that protects against infections caused by Streptococcus pneumoniae bacteria. This pamphlet explains why you may need to get vaccinated, possible side effects of the vaccine, and who should not get the vaccine.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2427
Lanthanum (Fosrenol) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35370
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1466
- Available Online
- View Pamphlet
Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Lanthanum
- Subjects (LCSH)
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Hemodialysis
- Abstract
- Lanthanum (LAN-tha-num) is a medication used to lower the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Lanthanum binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like lanthanam to remove more. Fosrenol® is the brand name for lanthanum. This pamphlet explains how to take lanthanum, possible side effects, and how to store this medication.
- Notes
- Previous title: Fosrenol (Lanthanum) and hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1466
Cinacalcet (Sensipar) for secondary hyperparathyroidism in chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35371
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1465
- Available Online
- View Pamphlet
Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinac…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Cinacalcet
- Renal Insufficiency, Chronic - drug therapy
- Hyperparathyroidism, Secondary - drug therapy
- Subjects (LCSH)
- Chronic renal failure
- Hyperparathyroidism
- Kidneys--Diseases--Treatment
- Abstract
- Secondary hyperparathyroidism is a condition that can be caused by chronic kidney disease (CKD). It happens when your kidneys cannot filter out waste products the right way. This leads to too much parathyroid hormone in your blood. Cinacalcet (sin-a-KAL-cet) is a medication that lowers the amount of parathyroid hormone in your blood. This will help to balance the amount of calcium and phosphorous in your blood. Sensipar® is the brand name for cinacalcet. This pamphlet explains how to take cinacalcet, possible side effects, and how to store this medication.
- Notes
- Previous title: Sensipar (Cinacalcet) to treat secondary hyperparathyroidism in chronic kidney disease
- Previous title: Cinacalcet (Sensipar) to treat secondary hyperparathyroidism in chronic kidney disease (CKD)
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1465
Sevelamer (Renagel) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35372
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1464
- Available Online
- View Pamphlet
Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra ph…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Sevelamer
- Renal Insufficiency, Chronic - drug therapy
- Renal Dialysis
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure
- Kidneys--Diseases--Treatment
- Abstract
- Sevelamer (se-VEL-a-mer) is a medication that lowers the amount of phosphorus (a mineral that builds strong bones and teeth) in your blood. Sevelamer binds (attaches) to the phosphorus in the foods you eat and stops your body from taking it in. A person with chronic kidney disease (CKD) is less able to remove phosphorus from their body. When there is too much phosphorus in your blood, it pushes calcium out of your bones. This makes your bones weaker. Hemodialysis can remove some of the extra phosphorus, but you may need a medication like sevelamer to remove more. Renagel® is one brand name for sevelamer. This pamphlet explains how to take sevelamer, possible side effects, and how to store this medication.
- Notes
- Previous title: Renagel (Sevelamer) and Hemodialysis
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1464
Oral irons and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35375
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1469
- Available Online
- View Pamphlet
Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Alternate Title
- Oral irons and CKD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Renal Insufficiency, Chronic - drug therapy
- Anemia, Iron-Deficiency - drug therapy
- Abstract
- Many people with chronic kidney disease (CKD) have anemia (not enough red blood cells or hemoglobin in the blood). Taking oral irons will give you enough iron to make hemoglobin. The pamphlet explains what oral irons are, how to take and store them, and possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1469
Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1493
- Available Online
- View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Anemia - drug therapy
- Subjects (LCSH)
- Chronic renal failure--Complications
- Renal anemia
- Abstract
- Erythropoiesis-stimulating agents (ESAs) are a group of medications that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1493
Injectable iron and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35408
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1495
- Available Online
- View Pamphlet
Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal Dialysis
- Iron - therapeutic use
- Kidney Diseases
- Anemia, Iron-Deficiency
- Subjects (LCSH)
- Hemodialysis
- Chronic renal failure--Complications
- Iron deficiency anemia
- Abstract
- Many people with chronic kidney disease (CKD), or who are on dialysis, have anemia because their red blood cells are low. The body needs iron to help make new red blood cells. This pamphlet explains how to take and store this medication, and lists possible side effects. The French version of this pamphlet 2161, "Fer injectable et insuffisance rénale chronique (IRC)," is also available.
- Notes
- Previous title: Injectable iron sucrose and chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1495
Tums (calcium carbonate) and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35431
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1514
- Available Online
- View Pamphlet
Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Calcium Carbonate - therapeutic use
- Kidney Diseases - drug therapy
- Subjects (LCSH)
- Calcium carbonate
- Kidneys--Diseases
- Specialty
- Nephrology
- Abstract
- Tums® (calcium carbonate) is a medication used to treat high levels of phosphorus in the body. This pamphlet explains why people with chronic kidney disease (CKD) need this medication and how to use it. The French version of this pamphlet 2236, "TumsMD (carbonate de calcium) et maladies rénales," is also available.
- Notes
- Tums (calcium carbonate) and kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1514
Over-the-counter medications and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35643
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1636
- Available Online
- View Pamphlet
If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (9 p.) : digital, PDF file
- Subjects (MeSH)
- Nonprescription Drugs
- Renal Insufficiency, Chronic - drug therapy
- Subjects (LCSH)
- Drugs, Nonprescription
- Chronic renal failure
- Abstract
- If you have chronic kidney disease (CKD), you need to know which over-the-counter medications are your best choices and which you should not take. This pamphlet lists over-the-counter medications you may need for a cough or cold, fever or pain, allergies, an upset stomach (indigestion, burning pain) or heartburn, nausea (feeling sick to your stomach) or vomiting (throwing up), diarrhea (loose, watery poop), and constipation, as well as multivitamins, and creams and ointments. Information on why you should not take any herbal or natural health products is included.
- Notes
- Previous title: Over-the-counter medications & chronic kidney disease
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1636
